Enterprise Therapeutics Stock
Enterprise Therapeutics is a drug discovery company focused on developing innovative therapies to treat respiratory diseases. The company targets mucus congestion and airway inflammation to improve breathing and provide relief for conditions like cystic fibrosis and COPD.
Founded: 2014
For more Enterprise Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| John Ford Chief Executive Officer |
| Martin Gosling Chief Scientific Officer |
| Phil Boyd Chief Financial Officer |
| Renu Gupta Chief Medical Officer |
